SCHEMBL29705106

SCHEMBL29705106

CCOC(=O)c1cn(CC(NC(=O)OC(C)(C)C)C(C)C)c2ncc(B(O)O)cc2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA7 P43166 1/20 0.38
LMNA P02545 2/20 0.35
ABCB1 P08183 1/20 0.35
KMT2A Q03164 2/20 0.33
PDE4B Q07343 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
RXFP1 Q9HBX9 1/20 0.32
MAPT P10636 1/20 0.32
ALDH1A1 P00352 4/20 0.32
KDM4E B2RXH2 3/20 0.32
HPGD P15428 3/20 0.32
HSD17B10 Q99714 2/20 0.32
MEN1 O00255 1/20 0.32
NPC1 O15118 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20521075 1.00 CA1 (0.38) CA1CA2CA7LMNAABCB1
SCHEMBL29705114 0.83 LMNA (0.37) LMNAKMT2ATDP1RXFP1ALDH1A1
SCHEMBL20520912 0.83 LMNA (0.37) LMNAKMT2ATDP1RXFP1ALDH1A1
SCHEMBL20521915 0.79 LMNA (0.39) LMNAKMT2APDE4BTDP1RXFP1
SCHEMBL29705124 0.79 LMNA (0.39) LMNAKMT2APDE4BTDP1RXFP1
SCHEMBL20521839 0.79 LMNA (0.50) LMNAKMT2ATDP1RXFP1MAPT
SCHEMBL29705211 0.79 LMNA (0.50) LMNAKMT2ATDP1RXFP1MAPT
SCHEMBL20521434 0.79 LMNA (0.41) LMNAKMT2ATDP1RXFP1MAPT
SCHEMBL20521317 0.77 LMNA (0.36) LMNAKMT2ATDP1RXFP1MAPT
SCHEMBL29705104 0.77 LMNA (0.36) LMNAKMT2ATDP1RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110475777-B Novel pyrido [2,3-b ] indole compounds for the treatment and prevention of bacterial infections 豪夫迈·罗氏有限公司 2022-04-15 CN disclosed